{"id":"https://openalex.org/W7208080549","doi":null,"title":"Strategy for Maintenance Therapy for Transplant-eligible and Non-eligible Patients with Multiple Myeloma","display_name":"Strategy for Maintenance Therapy for Transplant-eligible and Non-eligible Patients with Multiple Myeloma","publication_year":2023,"publication_date":"2023-12-25","ids":{"openalex":"https://openalex.org/W7208080549"},"language":"en","primary_location":{"id":"pmh:oai:irdb.nii.ac.jp:01433:0006028590","doi":null,"is_oa":true,"landing_page_url":"https://dmu.repo.nii.ac.jp/records/2000175","pdf_url":"https://dmu.repo.nii.ac.jp/record/2000175/files/DKMJ-2-4-2.pdf","source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dokkyo Medical Journal","raw_type":"journal article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://dmu.repo.nii.ac.jp/record/2000175/files/DKMJ-2-4-2.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021687301","display_name":"Yoichi Imai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I78274823","display_name":"Dokkyo Medical University","ror":"https://ror.org/05k27ay38","country_code":"JP","type":"education","lineage":["https://openalex.org/I78274823"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Imai, Yoichi","raw_affiliation_strings":["Department of Hematology and Oncology , Dokkyo Medical University , Tochigi , Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology , Dokkyo Medical University , Tochigi , Japan","institution_ids":["https://openalex.org/I78274823"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108755741","display_name":"Tomoyuki Handa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I78274823","display_name":"Dokkyo Medical University","ror":"https://ror.org/05k27ay38","country_code":"JP","type":"education","lineage":["https://openalex.org/I78274823"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Handa, Tomoyuki","raw_affiliation_strings":["Department of Hematology and Oncology , Dokkyo Medical University , 880 Kitakobayashi , Mibu , Shimotsuga , Tochigi 321- 0293 , Japan","Department of Hematology and Oncology , Dokkyo Medical University , Tochigi , Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology , Dokkyo Medical University , 880 Kitakobayashi , Mibu , Shimotsuga , Tochigi 321- 0293 , Japan","institution_ids":["https://openalex.org/I78274823"]},{"raw_affiliation_string":"Department of Hematology and Oncology , Dokkyo Medical University , Tochigi , Japan","institution_ids":["https://openalex.org/I78274823"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110125362","display_name":"Kinuko Mitani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I78274823","display_name":"Dokkyo Medical University","ror":"https://ror.org/05k27ay38","country_code":"JP","type":"education","lineage":["https://openalex.org/I78274823"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mitani, Kinuko","raw_affiliation_strings":["Department of Hematology and Oncology , Dokkyo Medical University , Tochigi , Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology , Dokkyo Medical University , Tochigi , Japan","institution_ids":["https://openalex.org/I78274823"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I78274823"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"2","issue":"4","first_page":"264","last_page":"274"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":1.0},{"id":"https://openalex.org/keywords/transplant-ineligible-patients","display_name":"transplant-ineligible patients","score":0.9330000281333923},{"id":"https://openalex.org/keywords/transplant-eligible-patients","display_name":"transplant-eligible patients","score":0.9739999771118164},{"id":"https://openalex.org/keywords/thalidomide","display_name":"thalidomide","score":0.8330000042915344},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.996999979019165},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ixazomib","display_name":"ixazomib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7049999833106995},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.8529999852180481},{"id":"https://openalex.org/keywords/driver-mutations","display_name":"driver mutations","score":0.6129999756813049},{"id":"https://openalex.org/keywords/immune-status","display_name":"immune status","score":0.8130000233650208},{"id":"https://openalex.org/keywords/high-dose-melphalan","display_name":"high-dose melphalan","score":0.6909999847412109},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.9670000076293945}],"concepts":[{"id":"https://openalex.org/C2781098529","wikidata":"https://www.wikidata.org/wiki/Q20948663","display_name":"Ixazomib","level":5,"score":0.9032999873161316},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.8870999813079834},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8062999844551086},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.7820000052452087},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7125999927520752},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5516999959945679},{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.536300003528595},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4683000147342682},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.4198000133037567},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.3666999936103821},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.36660000681877136},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3650999963283539},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3488999903202057},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.33880001306533813},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.29429998993873596},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.28999999165534973},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2867000102996826},{"id":"https://openalex.org/C2991767035","wikidata":"https://www.wikidata.org/wiki/Q179661","display_name":"Induction therapy","level":3,"score":0.2849999964237213},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.2824999988079071},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.28189998865127563},{"id":"https://openalex.org/C10882517","wikidata":"https://www.wikidata.org/wiki/Q15268054","display_name":"Cell therapy","level":3,"score":0.26570001244544983},{"id":"https://openalex.org/C2909984355","wikidata":"https://www.wikidata.org/wiki/Q2509220","display_name":"Hematologic malignancy","level":2,"score":0.25760000944137573}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:irdb.nii.ac.jp:01433:0006028590","doi":null,"is_oa":true,"landing_page_url":"https://dmu.repo.nii.ac.jp/records/2000175","pdf_url":"https://dmu.repo.nii.ac.jp/record/2000175/files/DKMJ-2-4-2.pdf","source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dokkyo Medical Journal","raw_type":"journal article"}],"best_oa_location":{"id":"pmh:oai:irdb.nii.ac.jp:01433:0006028590","doi":null,"is_oa":true,"landing_page_url":"https://dmu.repo.nii.ac.jp/records/2000175","pdf_url":"https://dmu.repo.nii.ac.jp/record/2000175/files/DKMJ-2-4-2.pdf","source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dokkyo Medical Journal","raw_type":"journal article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7208080549.pdf","grobid_xml":"https://content.openalex.org/works/W7208080549.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W2025013606","https://openalex.org/W2082741854","https://openalex.org/W2093757149","https://openalex.org/W2114217833","https://openalex.org/W2125721471","https://openalex.org/W2128084036","https://openalex.org/W2135514413","https://openalex.org/W2136373453","https://openalex.org/W2143425592","https://openalex.org/W2143860449","https://openalex.org/W2170805515","https://openalex.org/W2334764571","https://openalex.org/W2727891259","https://openalex.org/W2737964630","https://openalex.org/W2750997727","https://openalex.org/W2769593282","https://openalex.org/W3092622634","https://openalex.org/W4296713147","https://openalex.org/W4310106423"],"related_works":["https://openalex.org/W2190306783","https://openalex.org/W2904602769","https://openalex.org/W3032525343","https://openalex.org/W2038371375","https://openalex.org/W2599975475","https://openalex.org/W1877285685","https://openalex.org/W4282914785","https://openalex.org/W2767021776","https://openalex.org/W2018729528","https://openalex.org/W2109013784"],"abstract_inverted_index":{"Multiple":[0],"myeloma":[1],"(MM)":[2],"is":[3,65,95,138,150,232],"a":[4,48,147],"hematological":[5],"malignancy":[6],"originating":[7],"from":[8],"plasma":[9],"cells":[10],"producing":[11],"immunoglobulin.":[12],"Introducing":[13],"high-dose":[14],"melphalan":[15],"therapy":[16,39,42,62,72,105,149,169,188,225],"followed":[17],"by":[18],"auto":[19],"stem":[20],"cell":[21],"transplantation":[22],"(ASCT)":[23],"and":[24,75,108,125,140,183,226,229],"novel":[25],"drugs":[26],"has":[27,43],"improved":[28],"the":[29,85,100,141,155,158,181,216,219],"survival":[30,53],"of":[31,37,51,60,88,103,115,132,143,157,185,201,221],"patients":[32,110,172,191],"with":[33,92,111,192,198],"MM.":[34,112],"The":[35,58,113,129],"importance":[36],"maintenance":[38,61,104,119,148,168,187,224],"after":[40,55,70,211],"induction":[41,56,71,212],"been":[44],"investigated":[45],"to":[46,66,84,174,179,204],"obtain":[47],"long":[49],"duration":[50],"progression-free":[52],"(PFS)":[54],"therapy.":[57,213],"role":[59],"in":[63,189,223],"MM":[64,193],"inhibit":[67],"disease":[68],"progression":[69],"without":[73],"physical":[74],"financial":[76],"burden":[77,81,94],"for":[78,106,170],"patients.":[79],"Physical":[80],"mainly":[82],"refers":[83],"side":[86],"effects":[87],"treatment.":[89],"Preventing":[90],"relapse":[91],"minimum":[93],"beneficial.":[96],"Here,":[97],"we":[98,153,161],"review":[99],"updated":[101],"progress":[102],"transplant-eligible":[107],"-ineligible":[109],"results":[114,137],"clinical":[116,159],"studies":[117],"about":[118],"therapies":[120],"using":[121],"thalidomide,":[122],"lenalidomide,":[123],"bortezomib,":[124],"ixazomib":[126,167,186,222],"are":[127],"demonstrated.":[128],"possible":[130],"choice":[131],"treatment":[133],"based":[134],"on":[135],"these":[136],"suggested,":[139],"utility":[142],"drug":[144],"combination":[145],"as":[146],"discussed.":[151],"Furthermore,":[152],"describe":[154],"outline":[156],"trial":[160],"just":[162],"commenced.":[163],"We":[164],"started":[165],"an":[166],"transplant-ineligible":[171,190],"intolerant":[173],"lenalidomide":[175,202],"(IMTIL)":[176],"study":[177],"(UMIN000048285)":[178],"determine":[180],"efficacy":[182,220],"safety":[184],"who":[194],"cannot":[195],"be":[196],"treated":[197],"standard":[199],"doses":[200],"due":[203],"adverse":[205],"reactions":[206],"or":[207,210],"frailty":[208],"during":[209],"In":[214],"addition,":[215],"relationship":[217],"between":[218],"driver":[227],"mutation":[228],"immune":[230],"status":[231],"assessed.":[233]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-09-04T00:00:00"}